Experimental data indicate that Si may improve glucose tolerance, enhance insulin sensitivity, and modulate adipokine signaling, but these effects may be masked by antidiabetic pharmacotherapy and the complex metabolic milieu characteristic of CAD. The gene discussed is INS; the disease is coronary artery disorder.